OXYCONTIN Prolonged-release Tablet

Oxycodone HCl
10 mg
CONTINENTAL PHARMA
Pack size 20's Pack
Dispensing mode
Source
Agent
Retail Price 10.39 AED

Indications

OXYCONTIN Prolonged-release Tablet is used for: For the treatment of diarrhoea, pulmonary oedema and for the relief of moderate to moderately severe pain.

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Oxycodone HCl :

Mechanism of Action

Oxycodone acts as a weak agonist at mu, kappa, and delta opioid receptors within the central nervous system (CNS). Oxycodone primarily affects mu-type opioid receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as oxycodone also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (kappa-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (mu and delta receptor agonist). This results in hyperpolarization and reduced neuronal excitability.

Note

OXYCONTIN 10 mg Prolonged-release Tablet manufactured by CONTINENTAL PHARMA. Its generic name is Oxycodone HCl. OXYCONTIN is availble in Saudi Arabia. Farmaco SA drug index information on OXYCONTIN Prolonged-release Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Oxycodone HCl :